Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : 10-Bagger MINIMUM Rise from July 1, 2005 until December 31, -- Ignore unavailable to you. Want to Upgrade?

To: donpat who wrote (758)	11/2/2005 9:45:25 PM
From: Walkingshadow	Read Replies (1) \| Respond to of 1694

Menon has no affiliation with Harvard Medical School. See for yourself: hms.harvard.edu He may have gotten a PhD there at some point, but he doesn't seem to have done much there. He got 3 papers published 4 or 5 years ago on anticancer drugs, but he was just a co-author, not the lead author or senior author. He was 4th author on two papers related to Alimta about the same time. He has never published on AZT to the best of my knowledge. Looks to me like he basically has been a drone in the pharma sector. Obviously, NNVC is paying somebody at BI to do whatever "experiments" they want done. This is not very impressive at all, this is not the way things are done. T